Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia.

The prognostic implications of t(9;22)(q34;q11) were assessed at a median follow-up of 3.5 years in 434 children receiving intensive treatment for acute lymphoblastic leukemia (ALL). Four-year event-free and overall survivals were 81% and 88%, respectively, in 419 children lacking t(9;22), but were 0% and 20%, respectively, in 15 children with t(9;22) (P less than .001). Poor outcome for children with t(9;22)-positive ALL was particularly notable because we have reported improved survival in other historically poor prognosis ALL cytogenetic categories when treated with similarly intensive therapy. We recommend that very intensive treatment approaches, including bone marrow transplantation in first remission, be considered for all children with t(9;22)-positive ALL.

[1]  Y. Kodera,et al.  [Bone marrow transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia]. , 1991, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[2]  G. Grosveld,et al.  Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia-type 7 kb transcript. , 1990, Blood.

[3]  R. Gelber,et al.  Prognostic implications of cytogenetic studies in an intensively treated group of children with acute lymphoblastic leukemia. , 1989, Blood.

[4]  J. Rowley,et al.  Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukemia. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Raimondi,et al.  Comparative biochemical and cytogenetic studies of childhood acute lymphoblastic leukemia with the Philadelphia chromosome and other 22q 11 variants , 1989 .

[6]  K. Mills,et al.  The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients. , 1988, Blood.

[7]  J. Reiffers,et al.  Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  F. Behm,et al.  Clinical and biologic hallmarks of the Philadelphia chromosome in childhood acute lymphoblastic leukemia. , 1987, Blood.

[9]  F. Behm,et al.  Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia. , 1987, Blood.

[10]  A. Hagemeijer,et al.  bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia. , 1986, Blood.

[11]  R. Gelber,et al.  Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. , 1986, The New England journal of medicine.

[12]  A. Look,et al.  Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia. , 1986, Blood.

[13]  C. Berard,et al.  Presence of clonal chromosome abnormalities in virtually all cases of acute lymphoblastic leukemia. , 1985, The New England journal of medicine.

[14]  J. Lewis,et al.  Lymphoma presenting as a traumatic hematoma in an HTLV-III antibody-positive hemophiliac. , 1985, The New England journal of medicine.

[15]  H. Behrendt,et al.  Phenotypic and karyotypic properties of hyperdiploid acute lymphoblastic leukaemia of childhood , 1985, British journal of haematology.

[16]  Kees Stam,et al.  Structural organization of the bcr gene and its role in the Ph′ translocation , 1985, Nature.

[17]  C. Pui,et al.  Clinical relevance of lymphoblast biological features in children with acute lymphoblastic leukemia. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  A. Look,et al.  New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia , 1984, Cell.

[19]  S. Sallan,et al.  Cytogenetics of acute lymphoblastic leukaemia in children as a factor in the prediction of long‐term survival , 1982, British journal of haematology.

[20]  L. Robison,et al.  Philadelphia chromosome positive childhood acute lymphoblastic leukemia. , 1980, Blood.

[21]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[22]  J. Rowley.  A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.

[23]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[24]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[25]  S. Thibodeau,et al.  The bcr gene in Philadelphia chromosome positive acute lymphoblastic leukemia. , 1989, Blood.

[26]  J. Reuben,et al.  Phenotypic and molecular heterogeneity in Philadelphia chromosome-positive acute leukemia. , 1988, Blood.

[27]  F. Behm,et al.  Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Walker,et al.  Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. , 1986, Blood.

[29]  A. Hagemeijer,et al.  bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia. , 1986, Blood.

[30]  D. Reece,et al.  Allogeneic bone marrow transplantation for Philadelphia-chromosome positive acute lymphoblastic leukemia. , 1986, Leukemia research.

[31]  A. Robinson,et al.  Prognosis in acute lymphoblastic leukemia of childhood as determined by cytogenetic studies at diagnosis. , 1983, Medical and pediatric oncology.